Clinical Trial Results

2020

10th July:
Effect of risdiplam on Female Fertility and Menstruation - response from Roche to the Community

16th June:
Roche Presents New Data on SUNFISH & JEWELFISH Trials at the Cure SMA Annual 2020 virtual Conference

28th April:
Roche’s Risdiplam Shows Significant Improvement in Survival and Motor Milestones in Infants who have SMA Type 1

28th February:
Roche Completes Recruitment for JEWELFISH Clinical Trial

6th February:
Roche’s Risdiplam Showed Significant Improvement in Motor Function in People who have SMA Type 2 or 3

23rd January:
Roche’s Risdiplam Meets Primary Endpoint in pivotal FIREFISH Trial in Infants who have SMA Type 1
 

2019

12th November:
ROCHE’S RISDIPLAM MEETS PRIMARY ENDPOINT IN SUNFISH TRIAL IN PEOPLE WITH SMA TYPE 2 OR 3 SMA

7th October:
Roche presents data from the trials at Annual Congress of the world muscle society

31st May:

ROCHE PRESENTED DATA FROM ITS RISDIPLAM PIVOTAL FIREFISH AND SUNFISH STUDIES AT THE 2019 AMERICAN ACADEMY OF NEUROLOGY ANNUAL CONFERENCE


2018

9th October: 
ROCHE ANNOUNCES SOME RESULTS FROM THEIR FIREFISH AND SUNFISH TRIALS

21st June: 
PTC THERAPEUTICS PRESENT INTERIM DATA FROM FIREFISH CLINICAL TRIAL

14th June: 
ROCHE UPDATE: SUNFISH TRIAL NOT GOING AHEAD IN THE UK


2017

19th September: 
RG7916 SUNFISH STUDY COMMUNITY UPDATE 

16th August: 
RG7916 FIREFISH TRIAL NOW ENROLLING PATIENTS

11th July: 
PTC THERAPEUTICS PROVIDE PRELIMINARY CLINICAL DATA ON RG7916


2016

22nd December: 
UPDATE FROM ROCHE ON THEIR CLINICAL TRIALS FOR 2017

27th September: 
ROCHE INITIATE PHASE II TRIAL OF RG7916

11th January: 
ROCHE PROVIDES UPDATES ON NEW COMPOUND AND MOONFISH TRIAL